Sodium Citrate And Citric Acid Solution
NDC Package 84447-017-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sodium Citrate And Citric Acid (sodium citrate and citric acid monohydrate) solution is sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. This formulation utilizes a solution delivery system. Marketed by Belleview Biosciences Llc, this product is identified by NDC 84447-017.

Identification & Billing

NDC Package Code
84447-017-01
Package Description
200000 mL in 1 DRUM
Product Code
84447-017
11-Digit Billing Format
84447001701
RxNorm Crosswalk
  • RxCUI: 543014 - citric acid 334 MG / sodium citrate 500 MG in 5 mL Oral Solution
  • RxCUI: 543014 - citric acid 66.8 MG/ML / sodium citrate 100 MG/ML Oral Solution
  • RxCUI: 543014 - citric acid 1002 MG / sodium citrate 1500 MG per 15 ML Oral Solution
  • RxCUI: 543014 - citric acid 2004 MG / sodium citrate 3000 MG per 30 ML Oral Solution
  • RxCUI: 543014 - citric acid 334 MG / sodium citrate 500 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Sodium Citrate And Citric Acid
Non-Proprietary Name
Sodium Citrate And Citric Acid Monohydrate
Substance Name
Anhydrous Citric Acid; Sodium Citrate
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively.Sodium Citrate and Citric Acid Oral Solution USP is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.

Regulatory & Marketing

Labeler Name
Belleview Biosciences Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
04-08-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84447-017-01 identifies a specific commercial package of 200000 ml in 1 drum of Sodium Citrate And Citric Acid, a human prescription drug labeled by Belleview Biosciences Llc. This solution is formulated for oral use and contains anhydrous citric acid; sodium citrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belleview Biosciences Llc on April 08, 2025. The current certification is valid through December 31, 2026.

How is this Belleview Biosciences Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84447001701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84447-017-01
11-Digit CMS (5-4-2)
84447-0017-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.